Comparison of diagnostic accuracy of 18F-FDG PET, 123I-IMT- and 99mTc-MIBI SPECT: Evaluation of tumour progression in irradiated low grade astrocytomas;Vergleich der diagnostischen genauigkeit von 18F-FDG PET, 123I-M-und 99mTc-MIBI SPECT zur ermittlung des progressionsstatus bestrahlter niedriggradiger astrozytome

NuklearMedizin

Volumn 45, Issue 1, 2006, Pages 49-56

  Henze, Marcus ^a   Ozdemir Sahin N ^a   Hipp, P ^a,b   Mier, W ^a   Eisenhut, M ^c   Debus, J ^a   Haberkorn, U ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b UNIVERSITY HOSPITAL ULM   (Germany)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Low grade astrocytoma; Radiotherapy; ROC analysis

Indexed keywords

ALPHA METHYL TYROSINE I 123; FLUORODEOXYGLUCOSE F 18; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG; 3 IODO ALPHA METHYLTYROSINE; 3-IODO-ALPHA-METHYLTYROSINE; DIAGNOSTIC AGENT; METIROSINE; RADIOISOTOPE;

ADULT; ARTICLE; ASTROCYTOMA; CANCER GRADING; CANCER RADIOTHERAPY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; FOLLOW UP; GRAY MATTER; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; ROC CURVE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TUMOR DIAGNOSIS; TUMOR GROWTH; WHITE MATTER; BRAIN TUMOR; COMPARATIVE STUDY; DISEASE COURSE; METHODOLOGY; MIDDLE AGED; PATHOLOGY; REPRODUCIBILITY; SCINTISCANNING;

ADULT; ASTROCYTOMA; BRAIN NEOPLASMS; DISEASE PROGRESSION; FEMALE; FLUORODEOXYGLUCOSE F18; FOLLOW-UP STUDIES; HUMANS; MALE; METHYLTYROSINES; MIDDLE AGED; RADIOISOTOPES; REPRODUCIBILITY OF RESULTS; TECHNETIUM TC 99M SESTAMIBI; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 33646898796     PISSN: 00295566     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0038-1623934     Document Type: Article

References (38)

1. Andrews RJ. Transhemispheric diaschisis: A review and comment. Stroke. 1991; 22: 943-9.
2. 18F] fluorodeoxyglucose PET in the detection and grading of recurrences in patients pretreated for gliomas at follow-up: a comparative study with stereotactic biopsy. Eur J Nucl Med 1999; 26: 144-51.
3. Baillet G, Albuquerque L, Chen Q et al. Evaluation of single-photon emission tomography imaging of supratentorial brain gliomas with technetium-99m sestamibi. Eur J Nucl Med 1994; 21: 1061-6.
4. Brix G, Zaers J, Adam LE et al. Performance evaluation of a whole-body PET scanner using the NEMA protocol. National Electrical Manufacturers Association. J Nucl Med 1997; 38: 1614-23.
5. Byrne TN. Imaging of gliomas. Semin Oncol 1994; 21: 162-71.
6. Chang LT. A method for attenuation correction in radionuclide computed tomography. IEEE Trans Nucl Sci 1978; 25: 638-43.
7. Delbeke D, Meyerowitz C, Lapidus RL et al. Optimal cutoff levels of F-18 fluorodeoxyglucose uptake in the differentiation of lowgrade from high-grade brain tumors with PET. Radiology 1995; 195: 47-52.
8. Di Chiro G, Brooks RA. PET quantitation: blessing and curse. J Nucl Med 1988; 29: 1603-4.
9. 123I-labelled compounds in clinical practice. Eur J Nucl Med 1999; 26: 655-8.
10. 99mTc-Tetrofosmin. Ann Nucl Med 2004; 18: 79-95.
11. 18F] fluorodeoxyglucose positron emission tomography. Ann Neurol 1991; 29(4): 347-55.
12. 123I-iodo-alpha-methyltyrosine in recurrent brain tumors Nuklearmedizin 1995; 34: 71-5.
13. 99mTc-MIBI SPET. Eur J Nucl Med Mol Imaging 2002; 29: 1455-61.
14. Henze M, Mohammed A, Schlemmer HP et al. PET and SPECT for detection of tumor progression in irradiated low-grade astrocytoma: a receiver-operating- characteristic analysis. J Nucl Med 2004; 45: 579-86.
15. Herfarth KK, Gutwein S, Debus J. Postoperative radiotherapy of astrocytomas. Sem Surg Oncol 2001; 20: 13-23.
16. Ishikawa M, Kikuchi H, Miyatake S et al. Glucose consumption in recurrent gliomas. Neurosurgery 1993; 33: 28-33.
17. Kubota R, Kubota K, Yamada S et al. Methionine uptake by tumor tissue: a microautoradiographic comparison with FDG. J Nucl Med 1995; 36: 484-92.
18. Kuwert T, Woesler B, Morgenroth C et al. Diagnosis of recurrent glioma with SPECT and iodine-123-alpha-methyl tyrosine. J Nucl Med 1998; 39: 23-7.
19. Lamy-Lhullier C, Dubois F, Blond S et al. Importance of cerebral tomoscintigraphy using technetium-labeled sestamibi in the differential diagnosis of current tumor vs. radiation necrosis in subtentorial glial tumors in the adult. Neurochirurgie 1999; 45: 110-7.
20. Landis SH, Murray T, Bolden S et al. Cancer statistics, 1999. CA Cancer J Clin 1999; 49: 8-31.
21. 124IMT and first clinical results. J Nucl Med 1990; 31: 281-6.
22. 123I]iodo-alpha-methyl tyrosine: competition with natural L-amino acids. J Nucl Med 1991; 32: 1225-9.
23. Langleben DD, Segall GM. PET in differentiation of recurrent brain tumor from radiation injury. J Nucl Med 2000; 41: 1861-7.
24. Leeds NE, Jackson EF. Current imaging techniques for the evaluation of brain neoplasms. Curr Opin Oncol 1994; 6: 254-61.
25. Maffioli L, Gasparini M, Chili A et al. Clinical role of technetium-99m sestamibi single-photon emission tomography in evaluating pretreated patients with brain rumours. Eur J Nucl Med 1996; 23: 308-11.
26. McCormack BM, Miller DC, Budzilovich GN et al. Treatment and survival of low-grade astrocytoma in adults: 1977-1988. Neurosurgery 1992; 31: 636-42.
27. Metz CE. Basic principles of ROC analysis. Seminars Nucl Med 1978; 8: 283-98.
28. 18F-FDG PET: ROC analyses. Eur J Nucl Med 2001; 28: 165-74.
29. Olivero WC, Dulebohn SC, Lister JR. The use of PET in evaluating patients with primary brain tumours: is it useful? J Neurol Neurosurg Psychiatry 1995; 58: 250-2.
30. 18F] fluorodeoxyglucose and positron emission tomography in the evaluation of radiation necrosis of the brain. Radiology 1982; 144: 885-9.
31. Ricci PE, Karis JP, Heiserman JE et al. Differentiating recurrent tumor from radiation necrosis: time for re-evaluation of positron emission tomography? AJNR Am J Neuroradiol 1998; 19: 407-13.
32. Soler C, Beauchesne P, Maatougui Ket al. Technetium-99m sestamibi brain single-photon emission tomography for detection of recurrent gliomas after radiation therapy. Eur J Nucl Med 1998; 25: 1649-57.
33. 99mTc-Sestamibi in high-grade malignant brain tumors reflect blood-brain barrier damage only? Neuroimage 2000; 12: 109-11.
34. Thompson TP, Lunsford LD, Kondziolka D. Distinguishing recurrent tumor and radiation necrosis with positron emission tomography versus stereotactic biopsy. Stereotact Fund Neurosurg 1999; 73: 9-14.
35. Vick NA, Ciric IS, Eller TW et al. Reoperation for malignant astrocytoma. Neurology 1989; 39: 430-2.
36. Weber W, Bartenstein P, Gross MW et al. Fluorine-18-FDG PET and iodine-123-IMT SPECT in the evaluation of brain tumors. J Nucl Med 1997; 38: 802-8.
37. l8F-deoxyglucose. Eur J Nucl Med 1997; 24: 428-34.
38. Zweig MH, Campbell G. Receiver-Operating Characteristic (ROC) Plots: A fundamental evaluation tool in clinical medicine. Clin Chem 1993; 39: 561-77.